<ѻý>How a Multi-Cancer Screening Test Would Play Out in the Clinicѻý> True positives identified with Grail's assay typically confirmed in under 2 months Oct 10, 2023
<ѻý>Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Liveѻý> News, features, and commentary about cancer-related issues Oct 06, 2023
<ѻý>Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBCѻý> Complete clinical response predicted favorable outcomes for up to 2 years Oct 06, 2023
<ѻý>Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panelѻý> But agency doesn't plan to immediately push for KRAS inhibitor's withdrawal Oct 05, 2023
<ѻý>Can ctDNA Guide Radiation Use in Oligometastatic NSCLC?ѻý> Detectable circulating tumor DNA before radiotherapy linked with worse survival Oct 05, 2023
<ѻý>FDA Panel Endorses DFMO for Kids' High-Risk Neuroblastoma in Remissionѻý> Large improvement in event-free survival, but questions linger about sources of data Oct 04, 2023
<ѻý>Use of Recent Diagnostic CT Scans for Palliative RT Planning Reduced Treatment Timeѻý> Time to treatment completion slashed by over 4 hours compared with CT simulation planning Oct 04, 2023
<ѻý>Drugmaker Plans to Pull Lung Cancer Therapy From the Marketѻý> Randomized trial of mobocertinib (Exkivity) failed to confirm benefit in rare tumor type Oct 04, 2023
<ѻý>FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLCѻý> Reviewers see potentially tiny PFS benefit with sotorasib, raise concerns over "systemic bias" Oct 04, 2023
<ѻý>Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RTѻý> Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says Oct 04, 2023
<ѻý>In BRCA Breast Cancer, Prophylactic Salpingo-Oophorectomy Tied to Better Survivalѻý> PSO should be performed early, particularly for those with the BRCA1 variant, researchers say Oct 04, 2023
<ѻý>SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancerѻý> Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
<ѻý>FDA Advisors to Consider DFMO Maintenance for High-Risk Neuroblastoma in Kidsѻý> Lack of options for relapsed disease versus uncertainty about supporting data Oct 03, 2023
<ѻý>FDA Greenlights Test for Cancer-Predisposing Genetic Mutationsѻý> First-of-its-kind DNA test achieved 99% accuracy for variants in dozens of genes Oct 03, 2023
<ѻý>Sexual Activity Lowers Risk of Side Effects After Cervical Cancer Treatmentѻý> Intercourse and/or vaginal dilation reduces risk of vaginal stenosis Oct 03, 2023
<ѻý>Preoperative Algorithm Might Halve Unnecessary Oophorectomies in Childrenѻý> Researchers point to potential for reduction in lifelong consequences Oct 03, 2023
<ѻý>ABIM CEO Retirement Comes Amid Wave of Criticismѻý> Richard Baron, MD, plans to step down as pushback against MOC grows Oct 02, 2023
<ѻý>SABR Offers New Hope for Older Patients With Inoperable Kidney Cancerѻý> Phase II study shows 100% local control and cancer-specific survival after more than 3 years Oct 01, 2023
<ѻý>IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myelomaѻý> Small retrospective study finds fewer severe infections during periods of replacement therapy Sep 29, 2023
<ѻý>New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancerѻý> Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
<ѻý>Anti-TIGIT Plus Immunotherapy 'Promising' in NSCLC, Esophageal Cancerѻý> Combination may "provide meaningful antitumor activity," researchers say Sep 28, 2023
<ѻý>Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screeningѻý> News, features, and commentary about cancer-related issues Sep 28, 2023
<ѻý>Report: Persistence of Gender Inequalities in Cancer Care, and a Call to Actionѻý> Premature deaths, lack of access to services, leadership inequalities highlighted Sep 27, 2023
<ѻý>Cancer Risk in NAFLD Higher With Early Disease Onsetѻý> 52% greater risk of malignancy for patients diagnosed with fatty liver disease before age 45 Sep 27, 2023
<ѻý>SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancerѻý> Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
<ѻý>Study Confirms Better Survival for HPV-Positive Cervical Cancerѻý> Source, interpretation of negative tests remain open to speculation Sep 26, 2023
<ѻý>When Screening Guidelines Collide, Who Wins?ѻý> A closer look at conflicting colorectal cancer screening recommendations Sep 26, 2023
<ѻý>Frontline Combo Yields High Remission Rate in Hairy Cell Leukemiaѻý> And almost all complete responders in small trial achieved MRD negativity Sep 25, 2023
<ѻý>Reduced Mortality Seen in Cancer Survivors Who Meet Exercise Guidelinesѻý> Survivors classified as exercisers have 25% reduced risk of all-cause mortality, study shows Sep 23, 2023
<ѻý>The White House Cancer Moonshot Is a Dudѻý> We're failing to take simple steps to reduce one of the biggest causes of cancer Sep 22, 2023
<ѻý>TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncologyѻý> News, features, and commentary about cancer-related issues Sep 21, 2023
<ѻý>Ultrasound May Help Early Breast Cancer Patients Avoid SLNBѻý> No axillary surgery matches SLNB for patients with a negative ultrasound of axillary lymph nodes Sep 21, 2023
<ѻý>Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancerѻý> Threefold risk reduction with enoxaparin in high-risk gastrointestinal, lung cancers Sep 21, 2023
<ѻý>Delaying Esophageal Cancer Surgery After Neoadjuvant CRT Fails in Trialѻý> Histological complete response rates no better and survival appears worse Sep 19, 2023
<ѻý>Large Study Eases Fears Over Zantac-Cancer Linkѻý> In multinational cohort, cancer incidence with pulled drug no different than other H2RAs Sep 19, 2023
<ѻý>Could Cetuximab Maintenance Play a Role in RAS Wild-Type Metastatic CRC?ѻý> Strategy tied to better outcomes but fails to meet primary goal of phase II trial Sep 18, 2023
<ѻý>FDA Approves JAK Inhibitor That Addresses Anemia in Myelofibrosisѻý> In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly Sep 18, 2023
<ѻý>Non-Erosive GERD May Not Increase Risk of Esophageal Cancerѻý> Study shows similar incidence rates to general population, unlike for those with erosive GERD Sep 18, 2023
<ѻý>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enoughѻý> Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<ѻý>Weight-Loss Surgery Tied to Lower Blood Cancer Risk in Womenѻý> Consider surgery for primary prevention in people with obesity, researchers suggest Sep 15, 2023